Free shipping— Canada $250+ CAD
PUFFINPEPTIDES
Voting candidateGHRP-6 research compound previewCatalogue preview · final packaging and presentation may vary if stocked

Five choices across your ballotUse votes only for compounds you would consider ordering

One vote per compoundEach candidate can be selected once on this browser

Flexible interest signalRemove or reassign a vote whenever you like

Help choose what Puffin stocks next
Performance Research

GHRP-6

GHRP-6 is a synthetic ghrelin-receptor agonist studied in growth-hormone release, appetite, and gastrointestinal-signalling models. It shares a receptor pathway with GHRP-2, hexarelin, and ipamorelin but not an identical response profile.

Voting round open One active vote per compound
Your ballot0 of 5 votes used

Loading your saved choices…

Interest onlyA vote is not an order, preorder, reservation, payment, or guarantee that this compound will be stocked.

GHRP-6 is currently being evaluated through customer voting and is not available to order. Final product specifications and batch documentation will be published only if it joins the catalogue.

Catalogue statusVoting candidate
CategoryPerformance Research
Research focusGhrelin-receptor activity
Ballot allowanceOne vote
Research guide

Understanding Ghrp-6

Explore the science, research focus, and key information behind this compound.

What is Ghrp-6?

Researchers compare GHRP-6 when both pituitary and appetite-related ghrelin signalling matter to the model.

What Researchers Study

Researchers examine Ghrelin-receptor activity, Appetite-signalling models, and Pituitary-response research.

How Ghrp-6 Works

By activating GHSR1a, GHRP-6 can stimulate pituitary GH release and engage appetite-related neural and peripheral signals. In plain language, it uses the ghrelin route, which connects endocrine release with feeding biology.

Research at a Glance

Acute GH and appetite responses have been observed. Small controlled studies support GHSR-mediated endocrine and feeding effects. They do not answer long-term safety, effectiveness, or body-composition questions. Same receptor family does not mean same selectivity. GHRP-2, GHRP-6, hexarelin, and ipamorelin differ in potency, endocrine spillover, and development history. Direct head-to-head design is more reliable than class-wide assumptions. Appetite can change downstream metabolic endpoints. A GHRP-6 study that measures body weight or nutrient handling should track food intake so a feeding response is not mistaken for a direct tissue effect.

Read the full Ghrp-6 evidence guideStudy design, primary sources, limitations, and unanswered questions.Open guide
Research-use statement

If this candidate is added to the catalogue, it would be offered for controlled laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement, or substitute for an approved product.